Akili, Inc. (NasdaqCM: AKLI)
Health Care · Health Care Technology · US
$—
— today · — 1Y
Akili, Inc. (NasdaqCM: AKLI) operates in the Health Care Technology industry within the Health Care sector.
Tweenvest scores Akili, Inc. across four factors: quality 36/100, value 67/100. Its strongest factor is value.
AKLI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $1.95M
- P/E
- —
- EPS
- -0.62
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 68
- Next earnings
- —
About Akili, Inc.
Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.
- ISIN
- US00974B1070
- Founded
- 2011
- Listed since
- Jun 30, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Natural Health Farm Holdings Inc.OTCPK: NHEL | $162.00 | $— | — |
| H-Source Holdings Ltd.OTCPK: HSCH.F | $118.00 | $— | — |
| Alternate Health Corp.OTCPK: AHGI.F | $91.00 | $0.00 | — |
| GAMERICA Holdings and Acquisitions Corp.OTCPK: VOIS | $89.00 | $— | — |
| Frélii, Inc.OTCPK: FRLI | $59.00 | $— | — |
| Binovi Technologies Corp.OTCPK: BNVI.F | $27.00 | $— | — |
| Easy Technologies Inc.OTCPK: EMYS.F | $10.00 | $— | — |
| HTG Molecular Diagnostics, Inc.OTCPK: HTGM.Q | $2.00 | $0.00 | — |
Figures last refreshed Oct 11, 2026.